Vertical Integration in Healthcare Transactions: Mitigating Risks and Creating Firewalls

A former healthcare corporate counsel, compliance, and privacy officer for a publicly traded healthcare company, Mr. Slavkin represents a variety of clients within the healthcare sector, providing guidance on complex issues and compliance with all appropriate federal and state statutes and regulations. These include federal anti-kickback, Stark laws, Medicare, Medicaid, HIPAA, and FDA regulations, as well as providing guidance on daily operational and compliance issues facing healthcare entities. Mr. Slavkin has significant experience with the Affordable Care Act and the ever-evolving role accountable care plays in U.S. health reform. Maintaining a robust thought leadership presence, he conducts frequent lectures throughout the U.S. on a wide array of healthcare issues, including compliance and development of compliance programs under the federal requirements, HIPAA matters, and other relevant issues.

Companies seeking antitrust clearance for their mergers and acquisitions, or that are parties or third parties in investigations and litigation launched by the FTC, the Antitrust Division of the DOJ, or state attorneys general, turn to Mr. Gilman for experienced and effective antitrust counsel. He leverages years of experience at the FTC, including three years as head of a merger division, to represent clients in a broad range of antitrust and competition matters, including antitrust diligence and deal negotiations, merger reviews and clearances, government investigations, Hart-Scott-Rodino and foreign merger notifications, civil conduct matters, general antitrust compliance, trade association counseling, and antitrust litigation. Mr. Gilmanʼs practice has a particular focus on representing merging parties and third parties in merger investigations by the FTC, DOJ, and state attorneys general. He brings significant prior government experience and knowledge to his client work, having joined the firm after seven years at the FTC, where, as assistant director, he led the 30-attorney Mergers IV Division and worked on some of the agencyʼs highest-profile matters.